Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Rakovina Therapeutics Inc. has announced a private placement offering, securing over $800,000 in initial commitments to advance their innovative cancer therapies. The funds will support the development of novel treatments using AI platforms, aiming for breakthroughs in DNA-damage response technologies.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.